Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP44 activates cell cycle. 3 / 3

| 1 2

➶

reach

"These results suggested that knockdown of USP44 might inhibit glioma cell proliferation by arresting cell cycle in G2/M phase."

28938551

➶

reach

"Our data showed that knockdown of USP44 arrested the cell cycle in G2/M phase concomitantly with the degradation of securin."

28938551

➶

eidos

"In addition , USP44 accelerated the cell cycle progression , with boosted cyclinD and PCNA levels ."

36483601

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...